Home
PODD
PODD News

Latest Insulet Corporation (PODD) News on July 26, 2024

Are Ozempic Jitters to Blame for DexCom's Stock-Price Plunge?

The Wall Street Journal

10 hours ago

Are Ozempic Jitters to Blame for DexCom's Stock-Price Plunge?

MT Newswires

11 hours ago

Insulet Shares Rise Pre-Bell After Company Posts Higher Preliminary Q2 Revenue

Insulet Reports Preliminary Second Quarter 2024 Revenue Results

Business Wire

14 hours ago

Insulet Reports Preliminary Second Quarter 2024 Revenue Results

All You Need to Know About Insulet (PODD) Rating Upgrade to Strong Buy

Zacks

8 days ago

All You Need to Know About Insulet (PODD) Rating Upgrade to Strong Buy

Should You Be Impressed By Insulet Corporation's (NASDAQ:PODD) ROE?

Simply Wall St.

14 days ago

Should You Be Impressed By Insulet Corporation's (NASDAQ:PODD) ROE?

Insulet to Announce Second Quarter 2024 Financial Results on August 8, 2024

Business Wire

19 days ago

Insulet to Announce Second Quarter 2024 Financial Results on August 8, 2024

Insulet Points Its Insulin Pump at the Big Diabetes Market: Type 2

Barrons.com

a month ago

Insulet Points Its Insulin Pump at the Big Diabetes Market: Type 2

ESLOY vs. PODD: Which Stock Is the Better Value Option?

Zacks

a month ago

ESLOY vs. PODD: Which Stock Is the Better Value Option?

Lilly Weight-Loss Drug Data Spurs Selloff in Sleep Apnea Stocks

Bloomberg

a month ago

Lilly Weight-Loss Drug Data Spurs Selloff in Sleep Apnea Stocks

Insulet's (PODD) Omnipod 5 Favored in Study for Type 2 Diabetes

Zacks

a month ago

Insulet's (PODD) Omnipod 5 Favored in Study for Type 2 Diabetes

Insulet seeks label expansion of Omnipod 5 for Type 2 diabetes

MedTech Dive

a month ago

Insulet seeks label expansion of Omnipod 5 for Type 2 diabetes

Insulet plans label expansion for Omnipod in type 2 diabetes

Medical Device Network

a month ago

Insulet plans label expansion for Omnipod in type 2 diabetes

Insulet’s SECURE-T2D Pivotal Trial Results Demonstrate Omnipod® 5 Improves Clinical Outcomes and Quality of Life in Type 2 Diabetes

Business Wire

a month ago

Insulet’s SECURE-T2D Pivotal Trial Results Demonstrate Omnipod® 5 Improves Clinical Outcomes and Quality of Life in Type 2 Diabetes

Insulet (PODD) Faces Increasing Competition

Insider Monkey

a month ago

Insulet (PODD) Faces Increasing Competition

Insulet (PODD) Unveils Key Achievements for the Omnipod 5 System

Zacks

a month ago

Insulet (PODD) Unveils Key Achievements for the Omnipod 5 System

MT Newswires

a month ago

Insulet Launches Omnipod 5 Tubeless Insulin System in the UK, Netherlands

Insulet Announces Full Commercial Launch of Omnipod 5 with Expanded Sensor Integrations in the United Kingdom and the Netherlands

Business Wire

a month ago

Insulet Announces Full Commercial Launch of Omnipod 5 with Expanded Sensor Integrations in the United Kingdom and the Netherlands

Insulet Announces Omnipod 5 Launch in France and U.S. Innovation Updates

Business Wire

a month ago

Insulet Announces Omnipod 5 Launch in France and U.S. Innovation Updates

Insider Sale at Insulet Corp (PODD) by SVP & Chief Technology Officer Mark Field

GuruFocus.com

a month ago

Insider Sale at Insulet Corp (PODD) by SVP & Chief Technology Officer Mark Field

MT Newswires

a month ago

Insulet Insider Sold Shares Worth $299,940, According to a Recent SEC Filing

Is Insulet (PODD) Stock an Apt Pick for Your Portfolio Now?

Zacks

a month ago

Is Insulet (PODD) Stock an Apt Pick for Your Portfolio Now?

Argus Research

a month ago

Daily – Vickers Top Buyers & Sellers for 06/12/2024

Insider Sale: Director Timothy Scannell Sells 7,000 Shares of Insulet Corp (PODD)

GuruFocus.com

a month ago

Insider Sale: Director Timothy Scannell Sells 7,000 Shares of Insulet Corp (PODD)

MT Newswires

a month ago

Insulet Insider Sold Shares Worth $405,806, According to a Recent SEC Filing

MT Newswires

a month ago

Insulet Insider Sold Shares Worth $1,333,570, According to a Recent SEC Filing

A Data-Driven Analysis of Netflix's Streaming Dominance and Future Outlook

GuruFocus.com

a month ago

A Data-Driven Analysis of Netflix's Streaming Dominance and Future Outlook

Energy Global

a month ago

ANDRITZ to equip new Silvan hydropower plant in Türkiye

Supreme Court Justice Alito talks polarization, his wife talks revenge in secret recordings

USA TODAY

a month ago

Supreme Court Justice Alito talks polarization, his wife talks revenge in secret recordings

Pacer ETFs Rings in its 9th Anniversary as Firm nears $50 Billion in Assets Under Management

Business Wire

a month ago

Pacer ETFs Rings in its 9th Anniversary as Firm nears $50 Billion in Assets Under Management

Indra Energy Drives Sustainability Focus through the Penguins Pledge with the Pittsburgh Penguins

Business Wire

a month ago

Indra Energy Drives Sustainability Focus through the Penguins Pledge with the Pittsburgh Penguins

SEALSQ to Launch Two New Quantum Resistant Chips

GlobeNewswire

a month ago

SEALSQ to Launch Two New Quantum Resistant Chips

Shrinking Fed rate cut expectations to keep US Treasury yields elevated: Reuters poll

Reuters

a month ago

Shrinking Fed rate cut expectations to keep US Treasury yields elevated: Reuters poll

Global Upstream Bioprocessing Market Analysis Report 2024-2030: A $59.24 Billion Market by 2030, Registering a CAGR of 14.3% from 2024 to 2030

GlobeNewswire

a month ago

Global Upstream Bioprocessing Market Analysis Report 2024-2030: A $59.24 Billion Market by 2030, Registering a CAGR of 14.3% from 2024 to 2030

PayPal upgraded, UiPath downgraded: Wall Street's top analyst calls

The Fly

2 months ago

PayPal upgraded, UiPath downgraded: Wall Street's top analyst calls

MT Newswires

2 months ago

Redburn Atlantic Initiates Insulet With Buy Rating, $235 Price Target

MT Newswires

2 months ago

Insulet Insider Sold Shares Worth $596,970, According to a Recent SEC Filing

Insulet to Present at the Jefferies Global Healthcare Conference

Business Wire

2 months ago

Insulet to Present at the Jefferies Global Healthcare Conference

Here's Why Insulet (PODD) is a Strong Momentum Stock

Zacks

2 months ago

Here's Why Insulet (PODD) is a Strong Momentum Stock

Why Insulet (PODD) is a Top Growth Stock for the Long-Term

Zacks

2 months ago

Why Insulet (PODD) is a Top Growth Stock for the Long-Term

Dexcom details plans for over-the-counter CGM as insulin pump firms seek Type 2 coverage

MedTech Dive

2 months ago

Dexcom details plans for over-the-counter CGM as insulin pump firms seek Type 2 coverage

Will Insulet's Monopoly Crumble? Appellate Court Ruling Signals Shift in Automated Insulin Delivery Systems Market

Benzinga

2 months ago

Will Insulet's Monopoly Crumble? Appellate Court Ruling Signals Shift in Automated Insulin Delivery Systems Market

Wall Street Trades Flat On Mixed Producer Inflation; Meme Stocks See Wild Ride, Bitcoin Drops: What's Driving Markets Tuesday?

Benzinga

2 months ago

Wall Street Trades Flat On Mixed Producer Inflation; Meme Stocks See Wild Ride, Bitcoin Drops: What's Driving Markets Tuesday?

MT Newswires

2 months ago

Insulet Shares Rise Despite Blue Orca's Short Position

Insulet (PODD) Q1 Earnings Top, 2024 Revenue View Raised

Zacks

2 months ago

Insulet (PODD) Q1 Earnings Top, 2024 Revenue View Raised

Results: Insulet Corporation Beat Earnings Expectations And Analysts Now Have New Forecasts

Simply Wall St.

2 months ago

Results: Insulet Corporation Beat Earnings Expectations And Analysts Now Have New Forecasts

Insulet Corporation (NASDAQ:PODD) Q1 2024 Earnings Call Transcript

Insider Monkey

3 months ago

Insulet Corporation (NASDAQ:PODD) Q1 2024 Earnings Call Transcript

GuruFocus.com

3 months ago

Insulet Corp (PODD) Reports Strong Q1 2024 Results and Raises Full-Year Guidance

Morningstar Research

3 months ago

Analyst Report: Insulet Corporation

MT Newswires

3 months ago

Raymond James Adjusts Price Target on Insulet to $213 From $218

MT Newswires

3 months ago

Wolfe Research Raises Price Target on Insulet to $205 From $200

MT Newswires

3 months ago

Canaccord Genuity Adjusts Price Target on Insulet to $234 From $226

MT Newswires

3 months ago

Jefferies Raises Price Target on Insulet to $260 From $255

Here's What Key Metrics Tell Us About Insulet (PODD) Q1 Earnings

Zacks

3 months ago

Here's What Key Metrics Tell Us About Insulet (PODD) Q1 Earnings

MT Newswires

3 months ago

Insulet Q1 Earnings, Revenue Rise; 2024 Revenue Growth Boosted

Associated Press Finance

3 months ago

Insulet: Q1 Earnings Snapshot

Insulet Reports First Quarter 2024 Revenue Increase of 23% Year-Over-Year

Business Wire

3 months ago

Insulet Reports First Quarter 2024 Revenue Increase of 23% Year-Over-Year

Nvidia, Micron and Super Micro among companies that shine in Wall Street’s ‘beat-and-raise’ game

MarketWatch

3 months ago

Nvidia, Micron and Super Micro among companies that shine in Wall Street’s ‘beat-and-raise’ game

Insulet’s 2023 Sustainability Report Highlights Commitment to Product Accessibility and Responsible Growth

Business Wire

3 months ago

Insulet’s 2023 Sustainability Report Highlights Commitment to Product Accessibility and Responsible Growth

Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick

Zacks

3 months ago

Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick

Gear Up for Insulet (PODD) Q1 Earnings: Wall Street Estimates for Key Metrics

Zacks

3 months ago

Gear Up for Insulet (PODD) Q1 Earnings: Wall Street Estimates for Key Metrics

Insulet (PODD) Rises Higher Than Market: Key Facts

Zacks

3 months ago

Insulet (PODD) Rises Higher Than Market: Key Facts

Why Insulet (PODD) is a Top Momentum Stock for the Long-Term

Zacks

3 months ago

Why Insulet (PODD) is a Top Momentum Stock for the Long-Term

American Politicians are Selling These 10 Stocks

Insider Monkey

3 months ago

American Politicians are Selling These 10 Stocks

Insulet (PODD) Outperforms Broader Market: What You Need to Know

Zacks

3 months ago

Insulet (PODD) Outperforms Broader Market: What You Need to Know

Why Investors Need to Take Advantage of These 2 Medical Stocks Now

Zacks

3 months ago

Why Investors Need to Take Advantage of These 2 Medical Stocks Now

Insulet (PODD) Awaits Q1 Earnings Release: Here's What to Expect

Zacks

3 months ago

Insulet (PODD) Awaits Q1 Earnings Release: Here's What to Expect

5 Large-Cap Medical Stocks to Buy Ahead of Q1 Earnings

Zacks

3 months ago

5 Large-Cap Medical Stocks to Buy Ahead of Q1 Earnings

Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio

Zacks

3 months ago

Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio

Abbott (ABT) Q1 Earnings Beat Estimates, Margins Contract

Zacks

3 months ago

Abbott (ABT) Q1 Earnings Beat Estimates, Margins Contract

Why Investors Need to Take Advantage of These 2 Medical Stocks Now

Zacks

3 months ago

Why Investors Need to Take Advantage of These 2 Medical Stocks Now

Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick

Zacks

3 months ago

Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick

Earnings growth outpaced the impressive 16% CAGR delivered to Insulet (NASDAQ:PODD) shareholders over the last five years

Simply Wall St.

3 months ago

Earnings growth outpaced the impressive 16% CAGR delivered to Insulet (NASDAQ:PODD) shareholders over the last five years

Will Insulet (PODD) Beat Estimates Again in Its Next Earnings Report?

Zacks

3 months ago

Will Insulet (PODD) Beat Estimates Again in Its Next Earnings Report?

Insulet (PODD) Stock Moves -0.34%: What You Should Know

Zacks

4 months ago

Insulet (PODD) Stock Moves -0.34%: What You Should Know

Neogen (NEOG) Q3 Earnings Miss Estimates, Gross Margin Expands

Zacks

4 months ago

Neogen (NEOG) Q3 Earnings Miss Estimates, Gross Margin Expands

Insulet to Announce First Quarter 2024 Financial Results on May 9, 2024

Business Wire

4 months ago

Insulet to Announce First Quarter 2024 Financial Results on May 9, 2024

Here's Why Insulet (PODD) is a Strong Growth Stock

Zacks

4 months ago

Here's Why Insulet (PODD) is a Strong Growth Stock

5 Medical Product Stocks to Buy Amid Industry Challenges

Zacks

4 months ago

5 Medical Product Stocks to Buy Amid Industry Challenges

Wall Street Analysts See a 38.87% Upside in Insulet (PODD): Can the Stock Really Move This High?

Zacks

4 months ago

Wall Street Analysts See a 38.87% Upside in Insulet (PODD): Can the Stock Really Move This High?

Investors Will Want Insulet's (NASDAQ:PODD) Growth In ROCE To Persist

Simply Wall St.

4 months ago

Investors Will Want Insulet's (NASDAQ:PODD) Growth In ROCE To Persist

The Zacks Analyst Blog Highlights Twilio, Zscaler, NextEra Energy, and American Water Works

Zacks

4 months ago

The Zacks Analyst Blog Highlights Twilio, Zscaler, NextEra Energy, and American Water Works

5 Stocks to Buy on the Dip to Gain From the Wall Street Rally

Zacks

4 months ago

5 Stocks to Buy on the Dip to Gain From the Wall Street Rally

Biogen, Moderna, and 6 More Healthcare Stocks That Wall Street Thinks Have Upside

Barrons.com

4 months ago

Biogen, Moderna, and 6 More Healthcare Stocks That Wall Street Thinks Have Upside

3 Strong Stocks Down at Least 30% to Buy Now

Zacks

4 months ago

3 Strong Stocks Down at Least 30% to Buy Now

Insulet names Ana Maria Chadwick CFO

MedTech Dive

4 months ago

Insulet names Ana Maria Chadwick CFO

10 NASDAQ Stocks with Biggest Upside

Insider Monkey

4 months ago

10 NASDAQ Stocks with Biggest Upside

Insulet Appoints Ana Maria Chadwick as Chief Financial Officer

Business Wire

4 months ago

Insulet Appoints Ana Maria Chadwick as Chief Financial Officer

Here’s Why Insulet (PODD) Detracted in Q4

Insider Monkey

4 months ago

Here’s Why Insulet (PODD) Detracted in Q4

Here's Why You Should Buy Insulet (PODD) Stock Right Now

Zacks

4 months ago

Here's Why You Should Buy Insulet (PODD) Stock Right Now

Why Insulet (PODD) is a Top Growth Stock for the Long-Term

Zacks

4 months ago

Why Insulet (PODD) is a Top Growth Stock for the Long-Term

Calculating The Fair Value Of Insulet Corporation (NASDAQ:PODD)

Simply Wall St.

5 months ago

Calculating The Fair Value Of Insulet Corporation (NASDAQ:PODD)

Insulet’s Randomized Controlled Trial (OP5-003) Demonstrates Omnipod® 5 Automated Insulin Delivery System is Superior to Pump Therapy

Business Wire

5 months ago

Insulet’s Randomized Controlled Trial (OP5-003) Demonstrates Omnipod® 5 Automated Insulin Delivery System is Superior to Pump Therapy

Insulet to Present Results from First Omnipod® 5 Randomized Controlled Trial (OP5-003) at the 17th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD)

Business Wire

5 months ago

Insulet to Present Results from First Omnipod® 5 Randomized Controlled Trial (OP5-003) at the 17th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD)

Is It Time to Buy the S&P 500's 3 Worst-Performing February Stocks?

Motley Fool

5 months ago

Is It Time to Buy the S&P 500's 3 Worst-Performing February Stocks?

Insulet sizes up competition as Tandem, Medtronic plan new insulin patch-pumps

MedTech Dive

5 months ago

Insulet sizes up competition as Tandem, Medtronic plan new insulin patch-pumps

Insulet (PODD) Q4 Earnings, Revenues Top Mark, Margins Expand

Zacks

5 months ago

Insulet (PODD) Q4 Earnings, Revenues Top Mark, Margins Expand

Quanterix (QTRX) Expands in Alzheimer's Testing With Alliances

Zacks

5 months ago

Quanterix (QTRX) Expands in Alzheimer's Testing With Alliances

Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick

Zacks

5 months ago

Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick

Down -15.31% in 4 Weeks, Here's Why You Should You Buy the Dip in Insulet (PODD)

Zacks

5 months ago

Down -15.31% in 4 Weeks, Here's Why You Should You Buy the Dip in Insulet (PODD)

Morningstar Research

5 months ago

Analyst Report: Insulet Corporation

Share on Social Networks: